Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05240339 · ClinicalTrials.gov registry record
Characterization and Progression of Minor Phenomena in Parkinson's Disease (PD)
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 38
- Enrollment target
NCT05240339: Completed study, sponsored by University of Rochester.
NCT05240339 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05240339 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
Parkinson's disease psychosis encompasses a range of symptoms, including minor phenomena, frank hallucinations, and delusions. Minor phenomena include passage hallucinations (fleeting sense of a person, animal or object passing in the periphery), presence hallucinations (feeling of nearby presence), and illusions (misrepresentation of external stimuli). Some forms of PD psychosis may be progressive. The primary objective of this study is to: 1\) To determine the cumulative probability of developing hallucinations or delusions over time in individuals with PD minor phenomena followed for 36 months.
Primary Outcome
Kaplan-Meier curves will be used to describe the cumulative probability of hallucinations and/or delusions over time. Participants will be determined to have met the primary endpoint if they have hallucinations and/or delusions on the basis of interview or initiate treatment with an antipsychotic medication.
Interventions
- OTHER Observation of minor phenomena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2019-04-25 |
| Est. Completion | 2023-12-31 |
What the finished NCT05240339 record still lists
NCT05240339 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observation of minor phenomena is the first listed.
NCT05240339 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05240339 about?
NCT05240339 is a clinical study titled "Characterization and Progression of Minor Phenomena in Parkinson's Disease (PD)". Parkinson's disease psychosis encompasses a range of symptoms, including minor phenomena, frank hallucinations, and delusions. Minor phenomena include passage hallucinations (fleeting sense of a person, animal or object passing in the periphery), presence hallucinations (feeling of nearby presence),...
What is the current status of trial NCT05240339?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2019-04-25. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05240339?
The interventions under investigation include: Observation of minor phenomena (OTHER).
Who is sponsoring clinical trial NCT05240339?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI